Page last updated: 2024-09-03

6-heptyne-2,5-diamine and Breast Neoplasms

6-heptyne-2,5-diamine has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bencsik, K; Boldizsár, M; Kálnay, A; Kremmer, T; Mihalik, R; Pályi, I; Turi, G	1

Other Studies

1 other study(ies) available for 6-heptyne-2,5-diamine and Breast Neoplasms

Article	Year
Effects of methylacetylenic putrescine, an ornithine decarboxylase inhibitor and potential novel anticancer agent, on human and mouse cancer cell lines. Anti-cancer drugs, 1999, Volume: 10, Issue:1 Topics: Alkynes; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Death; Cell Division; Cell Survival; Diamines; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Inhibitory Concentration 50; Leukemia P388; Male; Mice; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Polyamines; Prostatic Neoplasms; Thyroid Neoplasms; Tumor Cells, Cultured	1999

Article

Year

Effects of methylacetylenic putrescine, an ornithine decarboxylase inhibitor and potential novel anticancer agent, on human and mouse cancer cell lines.

Anti-cancer drugs, 1999, Volume: 10, Issue:1

Topics: Alkynes; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Death; Cell Division; Cell Survival; Diamines; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Inhibitory Concentration 50; Leukemia P388; Male; Mice; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Polyamines; Prostatic Neoplasms; Thyroid Neoplasms; Tumor Cells, Cultured

1999